Could this be because the company has not aggressively marketed it?

…o try it. In the four months since gepirone was approved as the first 5-HT1A agonist for depression, I haven’t received any requests. Crickets. Many of my colleagues haven’t even heard of the drug. Others associate it with buspirone, and are skeptical that it will effectively treat depression.
Is the FDA Being a Good Gatekeeper?
752
16
John Kruse MD, PhD
David Mokotoff, MD
·Follow
Jan 26, 2024
--
Could this be because the company has not aggressively marketed it? I don't recall seeing any TV ads for it either.
--
--
Written by David Mokotoff, MD
7K Followers
·2.4K Following
David Mokotoff is a top and boosted writer. He is a retired MD, passionate about health, medicine, gardening, and food, https://tinyurl.com/y7bjoqkd
Responses (1)
Help
Status
About
Careers
Press
Blog
Privacy
Terms
Text to speech
Teams